Specialists are debating calls to employ developmental medicines against an Ebola outbreak ravaging West Africa, the Canadian Press reports.
A number of analysts said distributing vaccines or drug treatments that are not fully tested may boost local distrust of officials that have been fighting the spread of Ebola hemorrhagic fever since March, the news agency reported on Wednesday. No fully vetted medicines currently exist for the disease, which as of Tuesday may have killed more than 500 people in Guinea, Liberia and Sierra Leone.
According to some opponents of using such medicines, any adverse side effects may threaten years of efforts to develop the drugs as a defense against the potential biological-weapon agent.
“It would be unethical to roll [developmental medicines] out now, in my opinion,” said David Heymann, a former World Health Organization assistant director general.
Officials could instead move, once the current threat subsides, to lay the groundwork for using such treatments to combat future outbreaks, Heymann argued. The World Health Organization could make such policy preparations in collaboration with drug developers and regional governments, he said.
One expert, though, pressed for immediately using Ebola countermeasures now in a late stage of development.
“Imagine if you take a region of Canada, America, Europe and you had 450 people dying of a viral hemorrhagic fever. It would just be unacceptable — and it’s unacceptable in West Africa,” said Jeremy Farrar, a tropical medicine and global health specialist at Oxford University.
- 1 How to Measure Trump’s Political Strength
- 2 Democrats Hold Better Odds of Winning the House Than the Senate
- 3 Judicial Crisis Network Airs New Pro-Gorsuch Spot in IN, MO, ND
- 4 Senate Approves Bill to Weaken Obamacare, Defund Planned Parenthood
- 5 Obamacare Enrollment Spiked Ahead of Mandate Tax Deadline
What We're Following See More »
A DHS report "found gaping holes in domestic nuclear detection and defense capabilities and massive failures during covert testing." A team put in place to assess our readiness capabilities found significant issues in detecting dangerous radioactive and nuclear materials, failing to do so in 30 percent of covert tests conducted over the course of the year. In far too many cases, the person operating the detection device had no idea how to use it. And when the operator did get a hit, he or she relayed sensitive information over unsecured open radio channels."
Donald Trump is planning to reverse an Obama-era order requiring that schools allow students to use the bathroom that coincides with their gender identity. Trump "has green-lighted the plan for the Justice Department and Education Department to send a “Dear Colleague” letter to schools rescinding the guidance." A case is going before the Supreme Court on March 28 in which Gavin Grimm, a transgender high school student, is suing his high school for forbidding him to use the men's room.
Retired Russian diplomats and members of Vladimir Putin's staff are compiling a dossier "on Donald Trump's psychological makeup" for the Russian leader. "Among its preliminary conclusions is that the new American leader is a risk-taker who can be naïve, according to a senior Kremlin adviser."